Search - tctmd.com

Displaying 81 - 100 of 353

Sort: Relevancy | Date

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Graham A. Cassel

September 16, 2014

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Presentation TCT 2014

CON Problematic and Challenged

Presenter: Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

PRO Continued Optimism

Presenter: Felix Mahfoud

September 16, 2014

Presentation TCT 2014

Unfavourable Anatomy Of Renal Arteries Should Not Be An Exclusion Criteria For Renal Sympathetic Denervation

Presenter: Alexander Plehn

September 16, 2014

Presentation TCT 2014

Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters

Presenter: Waleed Kadro

September 16, 2014

Presentation TCT 2014

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Horst Sievert

September 16, 2014

Presentation TCT 2014

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Presenter: Daniel Garcia

September 16, 2014

Presentation TCT 2014

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Presenter: Gregory Wilson

September 16, 2014

Presentation TCT 2014

Very Low Intravenous Contrast Dose (20cc) Protocol for Computed Tomography Angiography (CTA) Providing Comprehensive Cardiac and Vascular Assessment for Transcatheter Aortic Val___

Presenter: Todd Pulerwitz

September 16, 2014

Presentation TCT 2014

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

Presenter: Robert Whitbourn

September 16, 2014

Presentation TCT 2014

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Presenter: Alexander Plehn

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

Presentation TCT 2014

TCT 407: Evaluation of the Acute and Long-term Renal Artery Reinnervation Attempt Response Following Catheter-Based Renal Denervation in a Swine Model: An Immunohistochemical Characterization

Presenter: David P. Faxon, Armando Tellez, MD

September 15, 2014

Presentation TCT 2014

Pulmonary Artery Denervation for Pulmonary Hypertension: Results, Case Example, and Future Directions

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Shao Liang Chen

September 14, 2014

Presentation TCT 2014

Alternative Device-Based Modalities to Treat Hypertension

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Paul A. Sobotka

September 14, 2014

Presentation TCT 2014

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Mark C. Bates

September 14, 2014

Advertisement

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Case Presentation: A Complex Patient at High Risk for Contrast-Induced Nephropathy

Access Site and the Risk of Acute Kidney Injury

Clinical Trial Updates: RenalGuard, AVERT, etc.

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

CON Problematic and Challenged

PRO Continued Optimism

Unfavourable Anatomy Of Renal Arteries Should Not Be An Exclusion Criteria For Renal Sympathetic Denervation

Second generation devices for renal denervation give better renal blood flow when compared with 1st generation catheters

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Very Low Intravenous Contrast Dose (20cc) Protocol for Computed Tomography Angiography (CTA) Providing Comprehensive Cardiac and Vascular Assessment for Transcatheter Aortic Val___

Renal Artery Denervation With A New Simultaneous Multielectrode Catheter For Treatment Of Resistant Hypertension: 12-Month Update From The SYMPLICITY Spyral First-In-Man Study

24h Ambulatory Blood Pressure (ABPM) Change After Using The New Symplicity Spyral Renal Sympathetic Denervation Device In Patients With Resistant Hypertension ? First Results Fr___

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

TCT 407: Evaluation of the Acute and Long-term Renal Artery Reinnervation Attempt Response Following Catheter-Based Renal Denervation in a Swine Model: An Immunohistochemical Characterization

Pulmonary Artery Denervation for Pulmonary Hypertension: Results, Case Example, and Future Directions

Alternative Device-Based Modalities to Treat Hypertension

A Self-Expanding Nitinol Carotid Prosthesis to Treat Resistant Hypertension (Vascular Dynamics)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content